Join EVA Pharma, a leading pharmaceutical company dedicated to empowering the fight for Health and Well-being as a fundamental human right. Recognized and certified as a best place to work, we are committed to fostering a supportive and innovative environment for our team members.
We are looking for a strategic, commercially minded, technology-driven and value-oriented CTO – Digital & AI to shape the Group's technology vision and lead its digital and AI agenda across Eva Pharma Group, including EVA Medicine, Limitless Care and Care Point.
This is a Group-level leadership role focused on leveraging technology, data and AI to build competitive advantage, accelerate growth, enable new business models, enhance organizational capabilities and enhance customer and patient impact.
Reporting directly to the Group CEO, the CTO will define the Group's long-term technology, digital and AI vision and translate it into a strategic roadmap aligned with CEO and Board priorities.
The CTO will act as a strategic partner to the business — identifying how technology, data and emerging AI capabilities can transform business models, strengthen organizational capability, improve customer and patient experiences, and unlock new opportunities. The role will lead and align senior technology leaders across Digital, Product, Engineering, ERP, Data & AI, Infrastructure and Cybersecurity, ensuring a coherent Group-wide technology strategy, architecture and operating model.
The role will be accountable for ensuring that technology investments and initiatives deliver measurable business impact, value and return on investment, with clear priorities, outcomes and success measures.
EVA Pharma is dedicated to improving access to affordable, high-quality medicines around the world, focusing on three core pillars: innovation, development and sustainable access. The company leverages cutting-edge technology at two research centers bringing first-of-its-kind capabilities to the Middle East and Africa including mRNA research and development from AI prediction to biological products.
With a 5,000-strong team of professionals, EVA Pharma produces more than one million healthcare products a day at four state-of-the-art manufacturing facilities, which are internationally recognized for innovation, and have been approved by multiple regulatory agencies.
Guided by a relentless drive to ensure sustainable access to pressing yet unmet disease areas, the company’s product portfolio focuses on twelve therapeutic areas: Anti-infectives, metabolic health, bone, neuroscience, oncology, respiratory, gynecology, urology and andrology, pediatrics, ophthalmology, gastrointestinal tract, family medicine to meet both local and international demand.
EVA Pharma is one of the fastest-growing healthcare companies in the Middle East and Africa, with an extensive pan-African presence, while operating in more than 60 countries worldwide.
